Coronavirus Disease Weekly News 18April 2021
The news posted last week for the coronavirus 2019-nCoV (aka SARS-CoV-2), which produces COVID-19 disease, has been surveyed and some important articles are summarized here. The articles are more or less organized with general virus news and anecdotes first, then stories from around the US, followed by an increased number of items from other countries around the globe. Economic news related to COVID-19 is found here.
Please share this article - Go to very top of page, right hand side, for social media buttons.
Summary:
New US cases of the coronavirus continued to inch a bit higher this week, while deaths attributed to the virus continued to fall. New Covid infections during the week ending April 17th were 2.2% higher than during the week ending April 10th, and up 26.5% from the 7 days ending March 16th (a six month low), but still down 72.6% from the early January peak. US Covid deaths were down 2.5% from the prior week, and down 78.7%
Global Neurosurgical Devices Market To Show Startling Growth During Forecast Period 2021–2027
briefingwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from briefingwire.com Daily Mail and Mail on Sunday newspapers.
Stroke Not a Common Complication in COVID-19: New Studies
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Prothena Presents Phase 1 Study Results of PRX004 in Oral Presentation at AAN 2021
Slowing of neuropathy progression for all 7 evaluable patients, evidenced by a +1.29 point mean change in NIS, was more favorable than expected progression of +9.2 points
Improvement in neuropathy for 3 of these 7 evaluable patients demonstrated by a mean change in NIS of -3.33 points
Improvement in cardiac function for all 7 evaluable patients demonstrated by a decrease in global longitudinal strain (GLS)
Emerging Science Oral Presentation today at AAN 2021
DUBLIN, Ireland, April 18, 2021 (GLOBE NEWSWIRE) Prothena Corporation plc (NASDAQ:PRTA) today presented positive results from the Phase 1 study of PRX004 as part of the Emerging Science Session at the American Academy of Neurology (AAN) 2021 Virtual Annual Meeting. PRX004 showed favorable results as demonstrated by slowing of neuropathy progression for all 7 evaluable patients at 9 months, including improvement in neuropathy in 3 of the
Share this article
Share this article
MINNEAPOLIS, April 17, 2021 /PRNewswire/ Half of the children who developed the serious condition associated with COVID-19 called multisystem inflammatory syndrome in children (MIS-C) had neurologic symptoms or signs when they entered the hospital, according to preliminary research that will be presented at the American Academy of Neurology s 73rd Annual Meeting being held virtually April 17 to 22, 2021. Those symptoms included headaches, encephalopathy and hallucinations. With this new inflammatory syndrome that develops after children are infected with the coronavirus, we are still learning how the syndrome affects children and what we need to watch out for, said study author Omar Abdel-Mannan, MD, of University College London in the United Kingdom and a member of the American Academy of Neurology. We found that many children experienced neurologic symptoms involving both the central and peripheral nervous systems.